We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFocusrite Regulatory News (TUNE)

Share Price Information for Focusrite (TUNE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 357.50
Bid: 350.00
Ask: 365.00
Change: 6.00 (1.69%)
Spread: 15.00 (4.286%)
Open: 357.50
High: 360.00
Low: 360.00
Prev. Close: 354.00
TUNE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director's Dealings

23 Nov 2017 10:21

RNS Number : 3533X
Focusrite PLC
23 November 2017
 

Focusrite Plc

 

("the Company" or "the Group")

 

Directors' Dealings

Grant of Share Options to Directors

 

Focusrite Plc (AIM:TUNE), the global music and audio products company that trades under the Focusrite and Novation brands, announces that on 22 November 2017 it issued 126,240 options under the Company's Performance Share Plan to Tim Carroll, CEO of the Company and Jeremy Wilson, CFO of the Company as listed below. The awards have a vesting date of 22 November 2020.

 

Director

Options granted

Tim Carroll

70,176

Jeremy Wilson

56,064

 

The performance measurement period is from 1 September 2017 to 31 August 2020 and the awards will vest subject to the rules of the Focusrite Plc Performance Share Plan and the Remuneration Committee's determination of the extent to which the performance conditions applicable to the award have been satisfied. Full details of these performance conditions are set out in the Company's Directors' Remuneration Report for the year ending 31 August 2017. Vested awards are exercisable until the tenth anniversary of the grant date, subject to the individual's ongoing employment.

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1

Details of the persons discharging managerial responsibilities person closely associated

a)

Name

1. Tim Carroll

3. Jeremy Wilson

2

Reason for the notification

a)

Position/status

 Directors of the Company

b)

Initial notification /Amendment

 Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Focusrite Plc

b)

LEI

213800JJ51KA4LOTF736

4

Details of the transaction(s): section to be repeated for (i) each type ofinstrument; (ii) each type of transaction; (iii) each date; and (iv) each placewhere transactions have been conducted

a)

Description of the financial instrument, type of instrument

Option over Ordinary Shares of 0.1p each

Identification code

GB00BSBMW716

b)

Nature of the transaction

Grant of options pursuant to the Focusrite Plc Performance Share Plan

c)

Price(s) and volume(s)

 

Exercise Prices per share

Volumes

1. 0.1p

2. 0.1p

1. 70,176

2. 56,064

 

d)

Aggregated information

- Aggregated volume 

- Price 

Weighted average exercise price: 0.1p per share

Aggregated volume: 126,240

e)

Date of the transaction

22 November 2017

f)

Place of the transaction

Outside a trading venue

 

 

-ends-

 

 

Enquiries:

 

Focusrite Plc:

 

Phil Dudderidge (Executive Chairman)

+44 1494 462246

Jeremy Wilson (CFO)

+44 1494 462246

 

 

Panmure Gordon

 

Freddy Crossley

+44 20 7886 2968

Tom Salvesen

+44 20 7886 2904

 

 

Belvedere Communications

 

John West

+44 20 3567 0510

Kim van Beeck

+44 20 3567 0510

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKNDDKBDDFDB
Date   Source Headline
25th Mar 20194:44 pmRNSGrant of Share Options to PDMR
19th Mar 20194:42 pmRNSTR-1
19th Mar 20197:00 amRNSTrading Update
11th Mar 20198:36 amRNSTR-1
28th Feb 20196:15 pmRNSTR-1
8th Feb 20197:00 amRNSNotification of transaction by PDMR
7th Feb 201910:32 amRNSHolding(s) in Company
6th Feb 20191:38 pmRNSHolding(s) in Company
28th Jan 20199:36 amRNSHolding(s) in Company
24th Jan 20192:57 pmRNSCompletion of Secondary Placing of Shares
24th Jan 20197:00 amRNSProposed Secondary Placing of Shares
21st Dec 201812:20 pmRNSResult of 2018 Annual General Meeting
21st Dec 20187:00 amRNSAGM Statement and Update on Trading
14th Dec 201810:14 amRNSDirectors' Dealings
4th Dec 20187:00 amRNSExercise of Share Options
3rd Dec 20183:12 pmRNSExercise of Share Options by a PDMR
26th Nov 20183:36 pmRNSGrant of Share Options to Directors
23rd Nov 201812:34 pmRNSDirector/PDMR Shareholding
23rd Nov 201812:29 pmRNSDirector/PDMR Shareholding
20th Nov 20187:00 amRNSFinal Results for the Year Ended 31 August 2018
8th Nov 20184:12 pmRNSHolding(s) in Company
18th Sep 20187:00 amRNSTrading Update
27th Jul 20189:45 amRNSTR-1
3rd Jul 201810:53 amRNSTR-1
29th May 20187:00 amRNSAppointment of Non-executive director
18th May 20185:06 pmRNSHolding(s) in Company
8th May 20189:31 amRNSDirector/PDMR Shareholding
3rd May 201812:18 pmRNSHolding(s) in Company
24th Apr 20187:00 amRNSHalf Year Results
9th Mar 20183:45 pmRNSDirector/PDMR Shareholding
9th Mar 20187:00 amRNSTrading Update
29th Jan 20183:38 pmRNSTR-1
29th Jan 201811:27 amRNSDirector/PDMR Shareholding
18th Jan 20187:00 amRNSDirector/PDMR Shareholding
10th Jan 20183:02 pmRNSResult of 2018 AGM
10th Jan 20187:00 amRNSAGM Statement and Update on Trading
19th Dec 20177:00 amRNSDirector/PDMR Shareholding
19th Dec 20177:00 amRNSDirector/PDMR Shareholding
15th Dec 20174:02 pmRNSDirector's Dealings
14th Dec 20179:56 amRNSDirector/PDMR Shareholding
5th Dec 201712:56 pmRNSTR-1: Standard form
30th Nov 20176:14 pmRNSCompletion of Secondary Placing of Shares
30th Nov 20174:35 pmRNSProposed Secondary Placing of Shares
24th Nov 20174:24 pmRNSPDMR Shareholding
23rd Nov 201710:22 amRNSPDMR Grant of Share Options
23rd Nov 201710:21 amRNSDirector's Dealings
23rd Nov 20177:00 amRNSDirector Share Dealings - Replacement
22nd Nov 20172:50 pmRNSDirector Share Dealings
21st Nov 20177:00 amRNSFinal Results for the Year Ended 31 August 2017
20th Sep 20172:54 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.